US-based radiation oncology firm Accuray will present its new Radixact treatment delivery system with augmented reality (AR) provider Zappar at the European Society for Radiotherapy & Oncology (ESTRO) meeting held in Vienna, Austria.
The Radixact is a fully integrated platform that employs megavoltage X-ray radiation, beamline and imaging technology to deliver precise treatments according to patient requirements.
Accuray adopted Zappar's new mixed reality technology to demonstrate the inner workings of its system.
The internal components and view of the physical machinery were exhibited through point codes that enable tracking of the digital content of the physical device using a mobile.
The mechanisms of the X-ray radiation, refined beamlines and fast imaging technology employed in the treatment delivery system were demonstrated to the customers.
Accuray chief marketing officer Birgit Fleurent said: “We are working with Zappar to present an alternative digital channel, which enables us to effectively demonstrate our products to a larger number of customers.
“As a company, we pride ourselves in providing innovative technology to the medical industry and our marketing solutions should be no different.
“We have achieved an overwhelmingly positive response to the mixed reality technology from this year’s attendees at ESTRO, which demonstrates just how valuable this type of innovation is for the industry.”
Zappar develops AR-enabled products and customisable market-leading solutions.
Zappar partnerships director Max Dawes said: “Mixed reality can add real value to the medical industry especially in conveying the features and benefits of highly technical pieces of machinery to customers.
“We were excited to work closely with Accuray to make sure we delivered a practical and engaging solution that demonstrated the company’s innovative product in the best possible way.”